Racial differences in the incidence of breast cancer subtypes defined by combined histologic grade and hormone receptor status

Cancer Causes and Control

Volumn 21, Issue 3, 2010, Pages 399-409

  Cunningham, Joan E ^a   Montero, Alberto J ^b   Garrett Mayer, Elizabeth ^a   Berkel, Hans J ^c   Ely, Bert ^d  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c ABC Consulting   (United States)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Breast cancer epidemiology; Health status disparities estrogen receptor; Histologic grade; Non SEER registry

Indexed keywords

ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER GRADING; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH DISPARITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RACE DIFFERENCE; UNITED STATES;

ADULT; AFRICAN AMERICANS; AGE FACTORS; AGED; BREAST NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MIDDLE AGED; NEOPLASM STAGING; OHIO; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; RECEPTOR, ERBB-3; RECEPTORS, ESTROGEN; REGISTRIES; RETROSPECTIVE STUDIES; SEER PROGRAM; SOUTH CAROLINA;

EID: 77950688982     PISSN: 09575243     EISSN: 15737225     Source Type: Journal    
DOI: 10.1007/s10552-009-9472-2     Document Type: Article

References (41)

1. Henson DE, Chu K, Levine PH (2003) Histologie grade, stage, and survival in breast carcinoma. Comparison of African American and Caucasian women. Cancer 98:908-917
2. Curtis E, Quale C, Haggstrom D, Smith-Bindman R (2008) Racial and ethnic differences in breast cancer survival: how much is explained by screening, tumor severity, biology, treatment, comorbidities, and demographics? Cancer 112:171-180
3. American Cancer Society (2007) Breast cancer facts & figures 2007-2008. American Cancer Society, Inc, Atlanta p. 3
4. Fitzgibbons PL, Page DL, Weaver D, Thor AD, Allred DC, Clark GM, Ruby SG et al (2000) Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:966-978
5. Greene F, Page DL, Fleming ID, Fritz A, Balch DM, Haller DG, Morrow M (eds) (2002) AJCC cancer staging manual. SpringerVerlag, New York
6. Volpi A, Bacci F, Paradiso A, Saragoni L, Scarpi E, Ricci M et al (2004) Prognostic relevance of histologic grade and its components in node-negative breast cancer patients. Mod Pathol 17:1038-1044 (Pubitemid 39128229)
7. Pinder SE, Murray S, Ellis IO, Trihia H, Elston CW, Gelber RD et al (1998) The importance of the histologic grade of invasive breast carcinoma and response to chemotherapy. Cancer 83:1529-1539 (Pubitemid 28465470)
8. Page DL, Gray R, Allred DC, Dressier LG, Hatfield AK, Martino S et al (2001) Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry: an Eastern Cooperative Oncology Group Study. Am J Clin Oncol 24:10-18 (Pubitemid 32178665)
9. Sohib LH, Wittekind C (2002) TNM classification of malignant tumours: International Union Against Cancer
10. Cunningham JE, Butler WM (2004) Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis even in small tumors. Breast Cancer Res Treat 88:161-176
11. Carey LA, Perou C, Livasy CA, Dressier LG, Cowan D, Conway K et al (2006) Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. JAMA 295:2492-2502 (Pubitemid 43854964)
12. Bauer KR, Brown M, Cress RD et al (2007) Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)negative, and HER2-negative invasive breast cancer, the socalled triple-negative phenotype: a population based study from the California cancer Registry. Cancer 109:1721-1728 (Pubitemid 46668532)
13. United States Department of Health and Human Services (US DHHS), Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) (2008) Bridged-race population estimates, United States July 1 st resident population by state, county, age, sex, bridged-race, and Hispanic origin, on CDC WONDER On-line Database. Vintage 2006: years 2000-2006, September 2007 online database, based on the August 16, 2007 data release. http://wonder.cdc.gov/bri.dged-.race-v2006.html
14. National Center for Health Statistics (NCHS) (2008) http://www. cdc.gov/nchs/about/m.ajor/dvs/popbridge/popbri.dge.htm
15. National Cancer Institute Surveillance Research Program (2008) http://seer.cancer.gov/stdpopulati.ons
16. North American Association of Central Cancer Registries (2008) http://www.cancer-rates.in.fo/naaccr/
17. Jensen OM, Parkin DM, MacLennan R, Muir CS, Skeet RG (eds) (1991) Cancer registration: principles and methods. Scientific Publication No. 95. International Agency for Research on Cancer. Lyon, France, p 138 (Equations 11.11 and 11.12)
18. Sørlie T, Perou C, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874 (Pubitemid 32878711)
19. Sørlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Børresen-Dale AL (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127
20. Reis-Filho JS, Tutt A (2008) Triple negative tumours: a critical review. Histopathology 52:108-118
21. Rakha EA, Ellis IO (2009) Triple-negative/basal-like breast cancer: review. Pathology 41(1):40-47
22. Asselin-Labat ML, Shackleton M, Stingl J, Vaillant F, Forrest NC, Eaves CJ et al (2006) Steroid hormone receptor status of mouse mammary stem cells. J Natl Cancer Inst 98:1011-1014 (Pubitemid 44288166)
23. Sims AH, Howell A, Howell SJ, Clarke RB (2007) Origins of breast cancer subtypes and therapeutic implications. Nat Clin Pract Oncol 4:516-525 (Pubitemid 47351462)
24. Melchor L, Benitz J (2008) An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes. Carcinogenesis 29(8): 1475-1482
25. Bloushtain-Qimron N, Yao J, Shipitsin M, Maruyama R, Polyak K (2009) Epigenetic patterns of embryonic and adult stem cells. Cell Cycle 8(6):806-817
26. Abdel-Fatah TMA, Powell D, Hodi Z, Reis-Filho JS, Lee AHS, Ellis IO (2008) Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family. Am J Surg Pathol 32(4):513-523 (Pubitemid 351458293)
27. Tlsty TD, Coussens LM (2006) Tumor stroma and regulation of cancer development. Ann Rev Pathol 1:119-150
28. Hunter KW, Crawford NP (2006) Germline polymorphism in metastatic progression. Cancer Res 66:1251-1254
29. Crawford NPS, Hunter K (2006) New perspectives on hereditary influences in metastatic progression. Trends Genet 22:555-561
30. Potter J, Cerhan JR, Sellers TA, McGovern PG, Drinkard C, Kushi LR, Folsom AR (1995) Progesterone and estrogen receptors and mammary neoplasia in the Iowa Women's Health Study: how many types of breast cancer are there? Cancer Epidemiol Biomark Prev 4:319-326
31. Li CI, Malone K, Porter PL, Weiss NS, Tang M-TC, Daling JR (2003) The relationship between alcohol use and risk of breast cancer by histology and hormone receptor status among women 65-79 years of age. Cancer Epidemiol Biomark Prev 12:1061-1066 (Pubitemid 37310263)
32. Smigal C, Jemal A, Ward E, Cokkinides V, Smith R, Howe HL, Thun M (2006) Trends in breast cancer by race and ethnicity: update 2006. CA Cancer J Clin 56:168-183 (Pubitemid 43847927)
33. Chen WY, Colditz G (2007) Risk factors and hormone-receptor status: epidemiology, risk-prediction models and treatment implications for breast cancer. Nat Clin Pract Oncol 4:415-423
34. Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B, Hewitt SM, Anderson WF, Szeszenia-Dabrowska N, Bardin-Mikolajczak A, Zatonski W, Cartun R, Mandich D, Rymkiewicz G, Ligaj M, Lukaszek S, Kordek R, Garcia-Closas M (2007) Differences in risk factors for breast cancer molecular subtypes in a population-based study. Cancer Epidemiol Biomarkers Prev 16(3):439-443 (Pubitemid 46548646)
35. Setiawan VW, Monroe KR, Wilkens LR, Kolonel LN, Pike MC, Henderson BE (2009) Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. AJE Adv Access
36. Stead L, Lash TL, Sobieraj J, Chi D, Westrup J, Chariot M, Blanchard R, Lee JC, King T, Rosenberg CL (2009) Triple negative breast cancers are increased in black women regardless of age or body mass index, Breast Cancer Res 11(2):R18 [Epub ahead of print.]
37. Karp SE, Tonin PN, Begin LR, Martinez JJ, Zhang JC, Pollak MN, Foulkes WD (1997) Influence of BRCAl mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women. Cancer 80:435-441
38. Anderson WF, Chen B, Brinton LA, Devesa SS (2007) Qualitative age interactions (or effect modification) suggest different cancer pathways for early-onset and late-onset breast cancers. Cancer Causes Control 18:1187-1198 (Pubitemid 47498167)
39. Anderson WF, Matsuno R (2006) Breast cancer heterogeneity: a mixture of at least two main types? J Natl Cancer Inst 98:948-951
40. Krieger N, Chen JT, Ware JH, Kaddour A (2008) Race/ethnicity and breast cancer estrogen receptor status: impact of class, missing data and modeling assumptions. Cancer Causes Control doi: 10.1007/s10552-008-9202-1
41. Robert SA, Strombom I, Trentham-Dietz A et al (2004) Socioeconomic risk factors for breast cancer: distinguishing individualand community-level effects. Epidemiology 15:442-450 (Pubitemid 40416932)